Last update 03 May 2026

[64Cu]FBP8

Overview

Basic Info

Drug Type
Peptide Conjugate Radionuclide, Diagnostic radiopharmaceuticals
Synonyms-
Target
fibrin
Action
modulators
Mechanism
fibrin modulators(Fibrin modulators)
Therapeutic Areas
Cardiovascular DiseasesEndocrinology and Metabolic DiseaseOther Diseases+ [3]
Active Indication
Senile cardiac amyloidosisThrombosisTransthyretin Amyloid Cardiomyopathy+ [3]
Inactive Indication
Pulmonary EmbolismVenous ThromboembolismVenous Thrombosis
Originator Organization
The General Hospital Corp.
Active Organization
The Brigham & Women's Hospital, Inc.The Brigham & Women's Hospital, Inc.The General Hospital Corp.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 3
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

Boost your research with our ADC technology data.
login
or
view full example data
Boost your research with our ADC technology data.

Related

4
Clinical Trials associated with [64Cu]FBP8
NCT07560306
/ RecruitingPhase 3IIT
[64Cu]FBP8 PET for Early Detection of Intracardiac Thrombus in Amyloid Cardiomyopathy
NCT05336695
/ RecruitingPhase 1/2IIT
Assess the Brain Levels of Fibrin in Alzheimer's Disease and Its Related Dementias Subjects Using 64Cu-FBP8 PET
NCT04022915
/ TerminatedPhase 1IIT
PET Fibrin Imaging of DVT and PE
100 Clinical Results associated with [64Cu]FBP8
Login to view more data
100 Translational Medicine associated with [64Cu]FBP8
Login to view more data
100 Patents (Medical) associated with [64Cu]FBP8
Login to view more data
100 Deals associated with [64Cu]FBP8
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Senile cardiac amyloidosisPhase 3
United States
The Brigham & Women's Hospital, Inc.The Brigham & Women's Hospital, Inc.
01 May 2026
ThrombosisPhase 3
United States
The Brigham & Women's Hospital, Inc.The Brigham & Women's Hospital, Inc.
01 May 2026
Transthyretin Amyloid CardiomyopathyPhase 3
United States
The Brigham & Women's Hospital, Inc.The Brigham & Women's Hospital, Inc.
01 May 2026
Alzheimer DiseasePhase 2
United States
The General Hospital Corp.
29 Mar 2022
Pulmonary EmbolismPhase 1
United States
The General Hospital Corp.
13 May 2019
Venous ThromboembolismPhase 1
United States
The General Hospital Corp.
13 May 2019
Venous ThrombosisPhase 1
United States
The General Hospital Corp.
13 May 2019
Atrial FibrillationPhase 1
United States
The General Hospital Corp.
01 Apr 2016
COVID-19Phase 1
United States
The General Hospital Corp.
01 Apr 2016
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
NCT04022915 (CTgov)
Phase 1
Pulmonary Embolism | Venous Thrombosis | Venous Thromboembolism
6
PET-CT imaging+64Cu-FBP8
xasucmlufa = dqdljvowsk syvqkjczht (duwngbeoms, rglzbgnucm - yqljijrmao)
View more
-
18 Mar 2026
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free